18 research outputs found
PO-0472 Evaluation Of Secretoneurin As Therapeutic Strategy In Neonatal Excitotoxic Brain Injury
Full text link311 The Sigma-Receptor-Agonist 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Decreases Neonatal Excitotoxic Brain Injury and Diminishes Microglial Cell Activation
Full text linkThe common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury
Full text linkPS-104 Early Markers Of An Increased Cardiovascular Risk In Former Preterm Tyrolean Preschoolers – Preliminary Data
Full text linkPO-0482 Secretoneurin As A Potential Diagnostic Marker Of Neonatal Hypoxic-ischaemic Encephalopathy
Full text linkPO-0396 The Sigma-1 Receptor Agonist Pre-084 Protects Against Glutamate Induced Neurotoxicity In Primary Hippocampal Neurons
Full text link9 The Sigma-1 Receptor Agonist PRE-084 Attenuates Inflammation-Sensitized Nmdar-Mediated Excitotoxic Brain Injury in Newborn Mice
Full text link1083 The Highly Selective Sigma-1 Receptor Agonist Pre-084 Reduces Inflammation-Sensitized Hyperoxia-Induced Injury in the Developing Rat Brain
Full text link299 PRE-084, A Sigma-1 Receptor Ligand, Protects Against Excitotoxic Perinatal Brain Injury in Newborn Mice
Full text linkPO-0397 The Neuropeptide Secretoneurin Is Protective In Established<i>in Vivo</i>And<i>in Vitro</i>Models Of Neonatal Brain Injury
Full text link
